News
Zacks Investment Research on MSN19h
BMY Gets FDA Nod for Label Expansion of Opdivo plus Yervoy ComboBristol Myers Squibb BMY announced that it has obtained FDA approval for the label expansion of Opdivo (nivolumab) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback